Holliston, Mass., USA - April 21, 2015, Holliston, Mass., USA - Harvard Apparatus Regenerative Technology, a biotechnology company reports that David Green has resigned as CEO, president and chairman.
Article continues below
Mr. Green has been the President and a member of the board of directors of Harvard Bioscience since March 1996 and will remain a director.
Mr. Green's previous experiences include working as a strategy consultant with Monitor Company, a strategy consulting company, in Cambridge, Massachusetts and Johannesburg, South Africa from June 1991 until September 1995 and a brand manager for household products with Unilever PLC, a packaged consumer goods company, in London from September 1985 to February 1989.
Mr. Green currently sits on the Advisory Board of the Harvard Business School Healthcare Initiative and on the Executive Advisory Board of The University of Massachusetts Lowell Nanomanufacturing Center.
Mr. Green graduated from Oxford University with a B.A. Honors degree in physics and holds a M.B.A. degree with distinction from Harvard Business School.
John F. Kennedy, a member of the Company’s Board of Directors since December 2012, has been named Chairman of the Board of Directors.
Mr. Kennedy has served as a member of our Board of Directors since December 3, 2012. From June 2006 until his retirement in October 2008, he served as President and Chief Financial Officer of Nova Ventures Corporation, the management company providing executive management services to the operating companies of Nova Holdings LLC, Nova Analytics Corporation and Nova Technologies Corporation.
From 2002 to 2006, Mr. Kennedy served as the President and Chief Financial Officer of Nova Analytics Corporation, a worldwide supplier and integrator of analytical instruments. From 1999 to 2002, he served as the Senior Vice President, Finance, Chief Financial Officer and Treasurer of RSA Security Inc., an e-business security company.
Prior to joining RSA Security, Mr. Kennedy was Chief Financial Officer of Decalog, NV, a developer of enterprise investment management software, from 1998 to 1999. From 1993 to 1998, he served as Vice President of Finance, Chief Financial Officer and Treasurer of Natural MicroSystems Corporation, a telecommunications company.
Mr. Kennedy, a former CPA, also practiced as a public accountant at KPMG for six years. Mr. Kennedy currently serves on the Boards of Directors of Harvard Bioscience and Datacom Systems, Inc. He holds an M.S.B.A. in Accounting from the University of Massachusetts Amherst.
The board appointed Thomas McNaughton, currently the company’s Chief Financial Officer, as interim Chief Executive Officer while the Board conducts the search for a new President and Chief Executive Officer.
Mr. McNaughton was the Chief Financial Officer of Harvard Bioscience since November 2008. From 2007 to 2008, he was a consultant providing services primarily to an angel-investing group and a silicon manufacturing start-up.
From 2005 to 2007, Mr. McNaughton served as Vice President of Finance and Chief Financial Officer for Tivoli Audio, LLC, a venture capital-backed global manufacturer of premium audio systems.
Prior to joining Tivoli Audio, LLC, from 1990 to 2005, Mr. McNaughton served in various managerial positions in the areas of financial reporting, treasury, investor relations, and acquisitions within Cabot Corporation, and served from 2002 to 2005 as Finance Director, and as Chief Financial Officer of Cabot Supermetals. ■